197 related articles for article (PubMed ID: 17535973)
41. Infection of human papillomavirus type 18 and p53 codon 72 polymorphism in lung cancer patients from India.
Jain N; Singh V; Hedau S; Kumar S; Daga MK; Dewan R; Murthy NS; Husain SA; Das BC
Chest; 2005 Dec; 128(6):3999-4007. PubMed ID: 16354872
[TBL] [Abstract][Full Text] [Related]
42. TP53 Arg72Pro polymorphism and endometrial cancer risk: a meta-analysis.
Jiang DK; Yao L; Ren WH; Wang WZ; Peng B; Yu L
Med Oncol; 2011 Dec; 28(4):1129-35. PubMed ID: 20552298
[TBL] [Abstract][Full Text] [Related]
43. Influence of Arg72Pro polymorphisms of TP53 on the response of buccal cells to radiotherapy.
Pereira L; Carvalho MR; Fonseca CG; Lima SS; Cerqueira EM; Jorge W; Castro MC
Genet Mol Res; 2011 Dec; 10(4):3552-8. PubMed ID: 22194206
[TBL] [Abstract][Full Text] [Related]
44. The p53 codon 72 polymorphism and lung cancer risk.
Fan R; Wu MT; Miller D; Wain JC; Kelsey KT; Wiencke JK; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1037-42. PubMed ID: 11045785
[TBL] [Abstract][Full Text] [Related]
45. The p53 codon 72 proline allele is associated with p53 gene mutations in non-small cell lung cancer.
Hu Y; McDermott MP; Ahrendt SA
Clin Cancer Res; 2005 Apr; 11(7):2502-9. PubMed ID: 15814626
[TBL] [Abstract][Full Text] [Related]
46. Arg72Pro polymorphism of p53 may predict poor response to medical treatment in ulcerative colitis.
Vietri MT; Riegler G; Pellino G; Molinari AM; Cioffi M
Ann Ital Chir; 2014; 85(6):513-7. PubMed ID: 25712892
[TBL] [Abstract][Full Text] [Related]
47. p53: guardian AND suppressor of longevity?
Donehower LA
Exp Gerontol; 2005; 40(1-2):7-9. PubMed ID: 15664727
[TBL] [Abstract][Full Text] [Related]
48. Updated meta-analysis of the TP53 Arg72Pro polymorphism and gastric cancer risk.
Xiang B; Mi YY; Li TF; Liu PF
Asian Pac J Cancer Prev; 2012; 13(5):1787-91. PubMed ID: 22901123
[TBL] [Abstract][Full Text] [Related]
49. P53 codon 72 polymorphism and risk of gastric cancer in a Chinese population.
Shen H; Solari A; Wang X; Zhang Z; Xu Y; Wang L; Hu X; Guo J; Wei Q
Oncol Rep; 2004 May; 11(5):1115-20. PubMed ID: 15069555
[TBL] [Abstract][Full Text] [Related]
50. Meta-analysis of associations between the TP53 Arg72Pro polymorphism with risk of head and neck carcinomas based on case-control studies.
Ren WH; Jiang DK; Pei Y; Wang SQ; Yang XM; Yu L
Genet Mol Res; 2014 Jan; 13(1):103-14. PubMed ID: 24446292
[TBL] [Abstract][Full Text] [Related]
51. TP53 Arg72Pro and XPD Lys751Gln Gene Polymorphisms and Risk of Lung Cancer in Bangladeshi Patients.
Nairuz T; Rahman M; Bushra MU; Kabir Y
Asian Pac J Cancer Prev; 2020 Jul; 21(7):2091-2098. PubMed ID: 32711437
[TBL] [Abstract][Full Text] [Related]
52. Association of p53 codon 72 polymorphism and MDM2 SNP309 with clinical outcome of advanced nonsmall cell lung cancer.
Han JY; Lee GK; Jang DH; Lee SY; Lee JS
Cancer; 2008 Aug; 113(4):799-807. PubMed ID: 18618574
[TBL] [Abstract][Full Text] [Related]
53. Role of GSTM1 (Null/Present), GSTP1 (Ile105Val) and P53 (Arg72Pro) genetic polymorphisms and the risk of breast cancer: a case control study from South India.
Samson M; Swaminathan R; Rama R; Sridevi V; Nancy KN; Rajkumar T
Asian Pac J Cancer Prev; 2007; 8(2):253-7. PubMed ID: 17696741
[TBL] [Abstract][Full Text] [Related]
54. Gene-Environment Interaction between Arg72Pro SNP and Selected Environmental Exposures among Brazilian Women Diagnosed with Benign Breast Disease.
Da Costa RSS; Koifman RJ; Esteves VF; Schilling MPR; Koifman S; Silva IFD
Asian Pac J Cancer Prev; 2020 Dec; 21(12):3477-3485. PubMed ID: 33369442
[TBL] [Abstract][Full Text] [Related]
55. [Genetic polymorphism in MDM2 is associated with susceptibility to colorectal cancer in a Chinese population].
Liu JN; Zhang XM; Guo YL; Sun T; Lin DX; Wen T
Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):335-8. PubMed ID: 18953830
[TBL] [Abstract][Full Text] [Related]
56. The potential impact of P53 and APO-1 genetic polymorphisms on hepatitis C genotype 4a susceptibility.
Eskander EF; Abd-Rabou AA; Mohamed MS; Yahya SM; El Sherbini A; Shaker OG
Gene; 2014 Oct; 550(1):40-5. PubMed ID: 25108128
[TBL] [Abstract][Full Text] [Related]
57. Association of TP53 Codon 72 Arg>Pro Polymorphism with Breast and Lung Cancer Risk in the South Asian Population: A Meta-Analysis.
Jafrin S; Aziz MA; Anonna SN; Akter T; Naznin NE; Reza S; Islam MS
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1511-1519. PubMed ID: 32592343
[TBL] [Abstract][Full Text] [Related]
58. p53 codon 72 polymorphism in patients with gastric and colorectal cancer in a Korean population.
Song HR; Kweon SS; Kim HN; Piao JM; Yun WJ; Choi JS; Hwang JE; Yoon JY; Kim HR; Park YK; Kim SH; Choi YD; Shin MH
Gastric Cancer; 2011 Aug; 14(3):242-8. PubMed ID: 21461655
[TBL] [Abstract][Full Text] [Related]
59. TP53 Gene 72 Arg/Pro (rs1042522) Single Nucleotide Polymorphism Contribute to Increase the Risk of B-Chronic Lymphocytic Leukemia in the Sudanese Population.
Mohammed Basabaeen AA; Abdelgader EA; Babekir EA; Abdelrahim SO; Eltayeb NH; Altayeb OA; Fadul EA; Sabo A; Ibrahim IK
Asian Pac J Cancer Prev; 2019 May; 20(5):1579-1585. PubMed ID: 31128065
[TBL] [Abstract][Full Text] [Related]
60. P53 Arg72Pro polymorphism and bladder cancer risk--meta-analysis evidence for a link in Asians but not Caucasians.
Xu T; Xu ZC; Zou Q; Yu B; Huang XE
Asian Pac J Cancer Prev; 2012; 13(5):2349-54. PubMed ID: 22901221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
